BioBusiness

Editor of Pharmaceutical Technology Europe

Articles

Hovione has acquired start-up company, ExtremoChem, expanding its technology platforms.

Hovione Expands Technology Platforms with ExtremoChem Acquisition

Sterling is known as a global contract development and manufacturing organization, and their network spreads to a manufacturing site in Cramlington, United Kingdom, a recently GMP-licensed dedicated bioconjugation facility in Deeside, and a 111-acre site in Ringaskiddy, Ireland.

Sterling Pharma Acquires NewChem Technologies

Mirati’s focus on breakthrough cancer treatments will bolster Bristol Myers Squibb’s oncology portfolio.

Bristol Myers Squibb Acquires Mirati Therapeutics for up to $5.8 Billion

Biosynth has further strengthened its peptide division with the acquisition of  Pepceuticals.

Biosynth Strengthens Position in Peptide Field through Pepceuticals Acquisition

POINT is a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies in development for the treatment of cancer.

Lilly to Acquire POINT Biopharma 

Feliza Mirasol is the science editor for 

The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.

Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions Business

Optibrium announced on Aug. 31, 2023 the acquisition of BioPharmics to further expand the 3D drug design and modelling offering and to focus on research and development and application science.

Optibrium Acquires BioPharmics

Novo Nordisk receives the full rights to develop and commercialize the lead program.

Novo Nordisk Acquires Embark Biotech

Both companies have a focus to developing and commercializing treatments for rare diseases with a strong focus on patients and supporting communities with little to no existing therapeutic options.

Zevra Therapeutics to Acquire Acer Therapeutics 

Mike Hennessy Jr. is the President and CEO of 

Pharma's ability to continually reinvent itself will be critical in growing future business operations.

Mergers and Acquisitions